Sage Journals: Discover world-class research

Abstract

Utilizing chromatographically modified magnetic micro-particles is an innovative principle of sample preparation for quantitative analysis of small molecules in complex biomedical samples by liquid chromatography tandem mass spectrometry. Since no vacuum or pressure has to be applied—in contrast to cartridge based solid phase extraction protocols—the principle's main characteristics are potentially straightforward automation and a high extraction performance (in terms of μg of extraction material per μL of sample). Following first descriptions of the approach, this article reports, the validation of a magnetic particle-based, analytical method for the quantification of the immunosuppressant mycophenolic acid in plasma. This sample preparation technology has shown a good performance for this clinically relevant analyte. As a result, we conclude that further work towards the implementation of this technology in a multi-analyte approach on robotic systems, aiming towards a fully automated process, is justified.

Keywords

chromatography ferromagnetic micro particles LC-MS/MS quantification sample preparation

Get full access to this article

View all access options for this article.

References

Vogeser

Geiger

Herrmann

and Kobold

, “Sample preparation for liquid chromatography-tandem mass spectrometry using functionalized ferromagnetic micro-particles”, Clin. Biochem. 41, 1417 (2008). doi: 10.1016/j.clinbiochem.2008.08.001

Sukhanova

I.I.

Dikunets

M.A.

Viryus

E.D.

and Rodchenkov

G.M.

, “Magnetic separation as a new method for the extraction of small molecules from biological fluids of humans”, J. Anal. Chem. 66, 9:807–814 (2011). doi: 10.1134/S1061934811090164

Fiedler

G.M.

Leichtle

A.B.

Kase

Baumann

Ceglarek

Felix

Conrad

Witzigmann

Weimann

Schutte

Hauss

Buchler

and Thiery

, “Serum peptidome profiling revealed platelet factor 4 as a potential discriminating peptide associated with pancreatic cancer”, Clin. Cancer Res. 15, 3812 (2009). doi: 10.1158/1078-0432.CCR-08-2701

Fiedler

G.M.

Baumann

Leichtle

Oltmann

Kase

Thiery

and Ceglarek

, “Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry”, Clin. Chem. 53, 421 (2007).doi: 10.1373/clinchem.2006.077834

Verheyen

Kaiser

Bozic

Timmen-Wego

Maier

B.K.

and Kessler

H.H.

, “Extraction of viral nucleic acids: Comparison of five automated nucleic acid extraction platforms”, J. Clin. Virol. 54, 255 (2012). doi: 10.1016/j.jcv.2012.03.008

Kole

P.L.

Venkatesh

Kotecha

and Sheshala

, “Recent advances in sample preparation techniques for effective bioanalytical methods”, Biomed. Chromatogr. 25, 199 (2011). doi: 10.1002/bmc.156

Vogeser

and Spohrer

, “Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry”, Clin. Chem. Lab. Med. 43, 400 (2005). doi: 10.1515/CCLM.2005.072

Vogeser

and Seger

, “A decade of HPLC-MS/MS in the routine clinical laboratory—goals for further developments”, Clin. Biochem. 41, 649 (2008). doi: 10.1016/j.clinbiochem.2008.02.017

van den Ouweland

J.M.

and Kema

I.P.

, “The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory”, J. Chromatogr. B 883/884,1 (2012). doi: 10.1016/j.jchromb.2011.11.044

10.

Patel

C.G.

Mendonza

A.E.

Akhlaghi

Majid

Trull

A.K.

Lee

and Holt

D.W.

, “Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry”, J. Chromatogr. B 813, 1–2:287–294 (2004). doi: 10.1016/j.jchromb.2004.10.004

11.

Annesley

T.M.

and Clayton

L.T.

, “Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry”, Clin. Chem. 51, 872 (2005). doi: 10.1373/clinchem.2004.047357

12.

Buchwald

Winkler

and Epting

, “Validation of an LC-MS/MS method to determine five immunosup-pressants with deuterated internal standards including MPA”, BMC Clin. Pharmacol. 12, (2012), doi: 10.1186/1472-6904-12-2

13.

Westley

I.S.

Sallustio

B.C.

and Morris

R.G.

, “Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma”, Clin. Biochem. 38, 824 (2005). doi: 10.1016/j.clinbiochem.2005.05.008

14.

Vogeser

Zachoval

Spohrer

and Jacob

, “Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum”, Ther. Drug Monit. 23, 722 (2012).

15.

Annesley

T.M.

, “Ion suppression in mass spectrometry”, Clin. Chem. 49, 1041 (2003).

16.

Kuo

H.T.

Yeh

J.Z.

Jiang

C.M.

and Wu

M.C.

, “Magnetic particle-linked anti hCG beta antibody for immunoassay of human chorionic gonadotropin (hCG), potential application to early pregnancy diagnosis”, J. Immunol. Methods 381, 32 (2012). doi: 10.1016/j.jim.2012.04.006

Sample Preparation for Measurement of Plasma Mycophenolic Acid Concentrations Using Chromatographically Functionalized Magnetic Micro-Particles

Abstract

Keywords

Get full access to this article

References